Comparator: niacin (+) laropiprant (MK0524A) + Comparator: placebo
Phase 3Terminated 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Hypercholesterolemia, Familial
Conditions
Hypercholesterolemia, Familial
Trial Timeline
Sep 1, 2006 → Aug 1, 2008
NCT ID
NCT00384293About Comparator: niacin (+) laropiprant (MK0524A) + Comparator: placebo
Comparator: niacin (+) laropiprant (MK0524A) + Comparator: placebo is a phase 3 stage product being developed by Merck for Hypercholesterolemia, Familial. The current trial status is terminated. This product is registered under clinical trial identifier NCT00384293. Target conditions include Hypercholesterolemia, Familial.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00384293 | Phase 3 | Terminated |
Competing Products
20 competing products in Hypercholesterolemia, Familial